1. Do you agree with the authors' assessment of the international pharmaceutical market and mechanisms for access to medicines;Will Open Access to essential medicines provide sufficient incentives for drug companies to invest in cures?[Read Flynn et al. (2009)]

2. Would these researchers support or disagree with Flynn et al. (2009), and why? [Read Kremer (2002) and Lybecker (2011)]

Free PDF readings:

Read Flynn et al. (2009): https://core.ac.uk/download/pdf/327252791.pdf

Read Kremer (2002): http://www2.econ.iastate.edu/faculty/bhattacharya/102h/pharma.pdf

Read Lybecker (2011): https://harvardilj.org/wp-content/uploads/sites/15/2011/12/HILJ-Online_53_Lybecker.pdf

ONCE IT IS BRIEFLY ANSWER ILL MAKE SURE TO PUT A THUMBS UP! THANK YOU